|
|
11755 Wilshire Blvd, Suite 2000
Los Angeles, CA 90025 USA
phone:(310) 405-7522
fax:(310) 998-8553
|
|
| Symbol |
ABBI |
| Exchange |
NASDAQ |
| Founded |
2005 |
| Employees |
|
|
|
| celgene.com/
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Cancer therapeutics and core technologies |
|
| Management |
| Lonnie Moulder, Vice Chairman, President and Chief Executive Officer; Patrick Soon-Shiong, M.D., Executive Chairman; Mary Lynne Hedley, Ph.D., Executive Vice-President and Chief Scientific Officer; Rick Rodgers, Senior Vice-President and Chief Financial Officer; Bruce Wendel, Executive Vice President, Corporate Development |
| |
|
|
|
|
|
|
|
| Keywords |
| oncology, nanoparticle, revolutionize, paclitaxel, neutrophil |
|
|
|
| Description |
|
Abraxis BioScience is a fully integrated biotechnology company dedicated to delivering progressive therapeutics and core technologies that offer patients and medical professionals safer and more effective treatments for cancer and other critical illnesses. The Abraxis portfolio includes the world's first and only protein-based nanoparticle chemotherapeutic compound (ABRAXANE) which is based on its proprietary tumor targeting system known as the nab Technology platform. From the discovery and research phase to development and commercialization, Abraxis BioScience is committed to rapidly enriching the company's pipeline and accelerating the delivery of breakthrough therapies that will transform the lives of the patients who need them. |
|
| Products / Services |
ABRAXANE® (for injectable suspension)
ISTODAX® (romidepsin) for injection
REVLIMID® (lenalidomide)
THALOMID® (thalidomide)
VIDAZA® (azacitidine for injection)
|
|
| Technology / Differentiation |
| When albumin is the key protein used in the ProtoSphere technology, the process is referred to as Abraxis proprietary nanoparticle albumin-bound or nab technology. The diagram below depicts the active drug surrounded by albumin. The electron micrograph shows results from the first clinical validation of nab technology. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
